PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer's disease.
暂无分享,去创建一个
E. Calabrese | R. Nemni | M. Clerici | M. Saresella | I. Marventano | F. Piancone | A. Gatti | M. Calvo
[1] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[2] T. Town,et al. CNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease? , 2009, Journal of Neuroimmune Pharmacology.
[3] Marina A. Lynch,et al. The Multifaceted Profile of Activated Microglia , 2009, Molecular Neurobiology.
[4] J. McLaurin,et al. Selective targeting of perivascular macrophages for clearance of β-amyloid in cerebral amyloid angiopathy , 2009, Proceedings of the National Academy of Sciences.
[5] R. Maserati,et al. Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases. , 2008, Clinical immunology.
[6] C. Palencia,et al. Fibrillar Amyloid-β Peptides Activate Microglia via TLR2: Implications for Alzheimer’s Disease1 , 2008, The Journal of Immunology.
[7] K. Kohyama,et al. Nonviral DNA Vaccination Augments Microglial Phagocytosis of &bgr;-Amyloid Deposits as a Major Clearance Pathway in an Alzheimer Disease Mouse Model , 2008, Journal of neuropathology and experimental neurology.
[8] Jun Tan,et al. Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology , 2008, Nature Medicine.
[9] M. O’Banion,et al. Chronic Interleukin-1β Expression in Mouse Brain Leads to Leukocyte Infiltration and Neutrophil-Independent Blood–Brain Barrier Permeability without Overt Neurodegeneration , 2007, The Journal of Neuroscience.
[10] P. Rossini,et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. , 2007, Blood.
[11] C. Tinelli,et al. Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients , 2007, Neurobiology of Aging.
[12] L. Stoltze,et al. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration , 2007, Journal of Neuroimmunology.
[13] V. Kuchroo,et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression , 2007, The Journal of experimental medicine.
[14] K. Venken,et al. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. , 2007, Journal of immunological methods.
[15] Michael T. Heneka,et al. Inflammatory processes in Alzheimer's disease , 2007, Journal of Neuroimmunology.
[16] L. Walker,et al. The role of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) in regulatory T‐cell biology , 2006, Immunological reviews.
[17] J. Myśliwska,et al. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. , 2006, Clinical immunology.
[18] A. Thomson,et al. Regulated Compartmentalization of Programmed Cell Death-1 Discriminates CD4+CD25+ Resting Regulatory T Cells from Activated T Cells1 , 2006, The Journal of Immunology.
[19] T. Town,et al. Journal of Neuroinflammation BioMed Central Review Involvement of β-chemokines in the development of inflammatory demyelination , 2005 .
[20] H. Chiu,et al. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease , 2005, Neurobiology of Aging.
[21] J. Bluestone,et al. Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell function , 2004 .
[22] S. Sakaguchi,et al. CD4+ Tregs and immune control. , 2004, The Journal of clinical investigation.
[23] C. Jack,et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.
[24] R. Petersen. Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.
[25] Nitin J. Karandikar,et al. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. , 2004, Blood.
[26] J. Witkowski,et al. Decreased proliferative capability of CD4+ cells of elderly people is associated with faster loss of activation-related antigens and accumulation of regulatory T cells , 2004, Experimental Gerontology.
[27] S. Sakaguchi. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.
[28] J. Alcocer-Varela,et al. Quantification of regulatory T cells in patients with systemic lupus erythematosus. , 2003, Journal of autoimmunity.
[29] D. Taramelli,et al. 1–40 β‐amyloid protein fragment modulates the expression of CD44 and CD71 on the astrocytoma cell line in the presence of IL1β and TNFα , 2003 .
[30] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[31] B. Small,et al. CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker of Alzheimer's disease , 2002, Journal of Neuroimmunology.
[32] M. Mullan,et al. CD40-CD40L interaction in Alzheimer's disease. , 2002, Current opinion in pharmacology.
[33] M. Shoji,et al. Cerebrospinal fluid Abeta40 and Abeta42: natural course and clinical usefulness. , 2002, Frontiers in bioscience : a journal and virtual library.
[34] L Scola,et al. Gender-specific association between −1082 IL-10 promoter polymorphism and longevity , 2002, Genes and Immunity.
[35] R. Ciubotariu,et al. CD8+CD28− T suppressor cells and the induction of antigen‐specific, antigen‐presenting cell‐mediated suppression of Th reactivity , 2001, Immunological reviews.
[36] A. Weverling-Rijnsburger,et al. Patients with Alzheimer's disease display a pro-inflammatory phenotype , 2001, Experimental Gerontology.
[37] A. B. Lyons,et al. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. , 2000, Journal of immunological methods.
[38] J. Shimizu,et al. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. , 2000, International immunology.
[39] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[40] C. Patlak,et al. In Vitro Evidence That β‐Amyloid Peptide 1–40 Diffuses Across the Blood–Brain Barrier and Affects Its Permeability , 2000, Journal of neuropathology and experimental neurology.
[41] E. Ferrari,et al. Overproduction of IFN‐γ and TNF‐α from Natural Killer (NK) Cells Is Associated with Abnormal NK Reactivity and Cognitive Derangement in Alzheimer's Disease , 2000 .
[42] Y. Wu,et al. Induction of CD40 on human endothelial cells by Alzheimer’s β-amyloid peptides , 1999, Brain Research Bulletin.
[43] R. Cacabelos,et al. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals , 1999, Journal of Neuroimmunology.
[44] T. Makinodan,et al. Age-related impaired proliferation of peripheral blood mononuclear cells is associated with an increase in both IL-10 and IL-12 , 1999, Experimental Gerontology.
[45] V. Singh,et al. Circulating cytokines in Alzheimer's disease. , 1997, Journal of psychiatric research.
[46] R. Rydel,et al. Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[47] C. Brodie,et al. T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease. , 1995, Clinical immunology and immunopathology.
[48] H. Müller-Hermelink,et al. Admission criteria for immunogerontological studies in man: The senieur protocol , 1984, Mechanisms of Ageing and Development.
[49] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[50] C. P. Hughes,et al. A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.
[51] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[52] G. Pawelec,et al. Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.
[53] R. Maccioni,et al. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. , 2008, Archives of medical research.
[54] S. Kim-Schulze,et al. Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. , 2005, International immunopharmacology.
[55] J. Bluestone,et al. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. , 2004, European journal of immunology.
[56] D. Taramelli,et al. 1-40 Beta-amyloid protein fragment modulates the expression of CD44 and CD71 on the astrocytoma cell line in the presence of IL1beta and TNFalpha. , 2003, Journal of cellular physiology.
[57] A. Rudensky,et al. Foxp 3 programs the development and function of CD 4 + CD 25 + regulatory T cells , 2003 .
[58] S. Hori,et al. Control of autoimmunity by naturally arising regulatory CD4+ T cells. , 2003, Advances in immunology.
[59] Svetlana Ten,et al. Multiple immuno-regulatory defects in type-1 diabetes. , 2002, The Journal of clinical investigation.
[60] Y. Wu,et al. Induction of CD40 on human endothelial cells by Alzheimer's beta-amyloid peptides. , 1999, Brain research bulletin.